Outcomes and readmissions in patients with nonalcoholic fatty liver disease undergoing catheter ablation for atrial fibrillation

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the United States, affecting approximately 15% to 30% of the general population ( 1 Fazel Y. Koenig A.B. Sayiner M. Goodman Z.D. Younossi Z.M. Epidemiology and natural history of non-alcoholic fatty liver disease. Metabolism. 2016 Aug; 65: 1017-1025 Google Scholar ). Catheter ablation for AF is safe, and it is associated with better clinical outcomes as compared to medical therapy ( 2 Asad Z.U.A. Yousif A. Khan M.S. Al-Khatib S.M. Stavrakis S. Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Circ Arrhythm Electrophysiol. 2019 Sep; 12e007414 Google Scholar ). However, there is limited data on clinical outcomes of patients with NAFLD undergoing catheter ablation for AF. Therefore, we examined the outcomes of patients with NAFLD undergoing AF ablation in a nationally representative cohort of patients.